Conrad Chapman
11Patents
5h-index
21Co-inventors
58Inventor score
Filing activity: Jun 6, 1995 → Oct 3, 2001
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5783181A | Therapeutic uses of fusion proteins between mutant IL 4/IL13 antagonists and immunoglobulins | Chemistry; Metallurgy | 69 | Expired |
| US6319689A | ASP2 | Human Necessities | 48 | Expired |
| US6025180A | ASP1 | Human Necessities | 36 | Expired |
| US6162630A | ASP1 | Human Necessities | 31 | Expired |
| US6870030B2 | ASP2 | Human Necessities | 19 | Expired |
| US6426197B1 | Polynucleotides encoding a human potassium channel | Physics | 5 | Expired |
| US6242217A | h-TREK1 polypeptides and h-TREK1 polynucleotides | Human Necessities | 2 | Expired |
| US6426405B2 | Neurotransmitter transporter SC6 | Human Necessities | 1 | Expired |
| US6180384A | Compounds | Chemistry; Metallurgy | 0 | Expired |
| US6294364A | Human FAS | Physics | 0 | Expired |
| US6238883A | Neurotransmitter transporter SC6 | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.